Juan Jesús
Gómez-Reino Carnota
Hospital Universitario La Paz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario La Paz (35)
2021
-
Update of the Position Paper of the Spanish Society of Rheumatology on Biosimilar Drugs
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 160-169
2019
2016
-
Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
Rheumatology International, Vol. 36, Núm. 8, pp. 1043-1063
-
Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search update
Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 16-22
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
-
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 3-15
2015
-
Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide
Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
Documento práctico para el uso de abatacept subcutáneo
Reumatologia Clinica, Vol. 10, Núm. 4, pp. 218-226
-
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study
Arthritis Research and Therapy, Vol. 16, Núm. 1
2013
-
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492
-
El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones
Reumatologia Clinica, Vol. 9, Núm. 1, pp. 5-17
2012
-
Treating rheumatoid arthritis to target: Recommendations of an international task force
Revmatologiia (Bulgaria), Vol. 20, Núm. 2, pp. 5-16
2011
-
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
Annals of the Rheumatic Diseases, Vol. 70, Núm. 3, pp. 404-413
-
American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
Arthritis and Rheumatism, Vol. 63, Núm. 3, pp. 573-586
-
Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire
Annals of the Rheumatic Diseases, Vol. 70, Núm. 11, pp. 1999-2002
2010
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Annals of the Rheumatic Diseases, Vol. 69, Núm. 6, pp. 964-975
-
Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression
Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68
-
Treating rheumatoid arthritis to target: Recommendations of an international task force
Annals of the Rheumatic Diseases, Vol. 69, Núm. 4, pp. 631-637
2009
-
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility
Arthritis Research and Therapy, Vol. 11, Núm. 2